Western blotting analysis showed that CTGF protein levels were upregulated in BLM-induced pulmonary fibrosis rats, and NFE (400 and 200 mg/kg) treatment downregulated its expression levels (Figure 5). The gene discussed is CCN2; the disease is pulmonary fibrosis.